ARTICLE | Distillery Therapeutics
Increasing hepatocyte RNF13 activity for NASH
November 28, 2023 12:43 AM UTC
Increasing hepatocyte expression of the E3 ubiquitin ligase RNF13 can help treat NASH by stabilizing the E3 ligase TRIM29, which promotes proteasomal degradation of the inflammation- and lipid accumulation-promoting signaling molecule STING.
In two human liver cancer cell lines exposed to a lipid accumulation and inflammation-inducing medium, a gain-of-function screen of plasmids encoding innate immunity-regulating E3 ligases and deubiquitinating enzymes identified RNF13 overexpression as a reducer of lipid accumulation. ...
BCIQ Company Profiles
BCIQ Target Profiles